BWX Technologies(BWXT)
Search documents
BWX Technologies(BWXT) - 2025 Q1 - Quarterly Report
2025-05-05 20:33
Financial Performance - Consolidated revenues increased by 13.0%, or $78.3 million, to $682.3 million for the three months ended March 31, 2025, compared to $604.0 million for the same period in 2024[95] - Government Operations segment revenues rose by 14.0%, or $68.2 million, to $555.3 million, driven by long-lead material procurements and the acquisition of Aerojet Ordnance Tennessee, Inc. (A.O.T.)[98] - Operating income for the Government Operations segment increased by $12.1 million to $97.7 million, maintaining a margin of 17.6%[99] - Commercial Operations segment revenues increased by 9.6%, or $11.3 million, to $128.3 million, primarily due to higher revenues in nuclear components manufacturing[101] - Operating income for the Commercial Operations segment decreased by $2.1 million to $6.5 million, with a margin of 5.0%[102] - For the three months ended March 31, 2025, income before provision for income taxes was $91,817 thousand, an increase of $3,440 thousand or 3.9% compared to $88,377 thousand for the same period in 2024[104] Taxation - The provision for income taxes decreased to $16,291 thousand in Q1 2025 from $19,843 thousand in Q1 2024, reflecting a reduction of $3,552 thousand or 17.9%[104] - The effective tax rate for Q1 2025 was 17.7%, down from 22.5% in Q1 2024, primarily due to excess tax benefits associated with equity compensation[105] Backlog and Revenue Recognition - As of March 31, 2025, total backlog was $4,878.7 million, slightly up from $4,843 million at the end of 2024, with $396.3 million of unfunded backlog related to U.S. Government contracts[110] - Approximately 61% of the revenue associated with the backlog is expected to be recognized by the end of 2026[110] Cash Flow and Capital Structure - Cash and cash equivalents totaled $70,465 thousand as of March 31, 2025, down from $91,180 thousand at December 31, 2024[133] - Working capital increased by $36.0 million to $491.8 million at March 31, 2025, primarily due to net changes in contracts in progress and advance billings[133] - Net cash provided by operating activities increased by $17.6 million to $50.7 million for the three months ended March 31, 2025, compared to $33.0 million for the same period in 2024[134] - Net cash used in investing activities increased by $126.0 million to $156.4 million for the three months ended March 31, 2025, primarily due to a $103.3 million acquisition of A.O.T.[135] - Net cash provided by financing activities increased by $116.9 million to $84.8 million for the three months ended March 31, 2025, driven by an increase in net borrowings of long-term debt of $123.4 million[136] Debt and Borrowings - As of March 31, 2025, borrowings under the Term Loan totaled $234.4 million, with total borrowings and letters of credit under the Revolving Credit Facility amounting to $170.0 million and $1.4 million, respectively[118] - The weighted-average interest rate on outstanding borrowings under the Credit Facility was 5.67% as of March 31, 2025[118] Acquisitions and Strategic Initiatives - The acquisition of A.O.T. on January 3, 2025, is expected to enhance capabilities in developing advanced materials for commercial, military, and space applications[86] - Kinectrics Holdings Inc. acquisition is targeted to close in mid-2025, expanding lifecycle management services for the nuclear power market[87] - The company entered into an agreement to acquire Kinectrics for approximately CAD 782.7 million, expected to close in mid-2025[139] Corporate Expenses and Financial Health - Unallocated corporate expenses increased by $6.3 million, attributed to higher healthcare costs and legal and consulting expenses related to merger and acquisition activities[103] - The company believes it has sufficient cash and borrowing capacity to meet cash requirements for the next 12 months and beyond[140] - The company had underfunded defined benefit pension and postretirement benefit plans with obligations totaling approximately $99.0 million as of March 31, 2025[132] Market Risk - Market risk exposures have not changed materially from those disclosed in the 2024 10-K[141]
BWX Technologies(BWXT) - 2025 Q1 - Quarterly Results
2025-05-05 20:31
Financial Performance - 1Q25 revenues reached $682.3 million, a 13% increase from $604.0 million in 1Q24[4] - Net income for 1Q25 was $75.5 million, up 10% from $68.5 million in 1Q24, with non-GAAP EPS increasing by 20% to $0.91[4][5] - Adjusted EBITDA for 1Q25 was $129.8 million, reflecting a 13% increase from $115.2 million in 1Q24[4][9] - Operating income for Q1 2025 was reported at $96.6 million, compared to $93.0 million in Q1 2024, indicating a growth of about 3.9%[41] - Net income for the three months ended March 31, 2025, was $75,526,000, an increase of 10.3% compared to $68,534,000 in the same period of 2024[43] - Total revenues for the first quarter of 2025 reached $682,258,000, up 13.0% from $603,966,000 in Q1 2024[49] Revenue Segmentation - Government Operations revenue increased by 14% to $555.3 million, driven by higher naval nuclear component production[5][6] - Commercial Operations revenue rose by 10% to $128.3 million, supported by increased sales in commercial nuclear components and medical sales[5][6] - Government Operations segment revenue increased to $555,286,000, a rise of 14.0% from $487,121,000 year-over-year[49] Cash Flow and Financial Health - Operating cash flow improved significantly by 53% to $50.7 million, attributed to higher net income and effective working capital management[4][9] - Free cash flow surged by 565% to $17.3 million, compared to $2.6 million in 1Q24[4][9] - Total cash provided by operating activities was $50,650,000, compared to $33,026,000 in the prior year, reflecting a 53.5% increase[43] - Cash and cash equivalents at the end of the period were $61,956,000, compared to $51,991,000 at the end of Q1 2024, representing a 19.1% increase[43] Guidance and Future Outlook - The company reaffirmed its 2025 non-GAAP EPS guidance of $3.40 to $3.55[4][11] - The acquisition of Kinectrics Inc. is on track to close in mid-2025, enhancing the company's capabilities[4][5] Investments and Expenditures - A land purchase in Oak Ridge, Tennessee, was made to support the U.S. Department of Energy's uranium enrichment program[4][5] - Capital expenditures for the quarter were $33,369,000, an increase of 9.9% from $30,422,000 in Q1 2024[49] Backlog and Bookings - The company reported a total backlog of $4,878,680,000, which is a 34.2% increase from $3,635,509,000 in the previous year[49] - Bookings for the total operations reached $719,817,000, significantly higher than $241,827,000 in the same quarter last year, marking a 197.0% increase[49] Other Financial Metrics - The effective tax rate for Q1 2025 was 17.7%, a decrease from 22.5% in Q1 2024, which may positively impact net income[41] - Long-term debt increased to $1,185,356,000 from $1,042,970,000, indicating a rise of 13.6%[47] - The company’s total assets grew to $3,054,008,000, up 6.4% from $2,869,924,000 at the end of 2024[45] - Research and development costs increased to $2.0 million in Q1 2025 from $1.5 million in Q1 2024, indicating a focus on innovation and development[41] - The company incurred $4.8 million in other income (expense) for Q1 2025, slightly higher than $4.6 million in Q1 2024[41]
BWX Technologies to Report Q1 Earnings: What's in Store for the Stock?
ZACKS· 2025-05-02 13:35
Core Viewpoint - BWX Technologies, Inc. (BWXT) is expected to report strong revenue growth in the first quarter of 2025, driven by increased manufacturing volume and strategic acquisitions, despite anticipated declines in earnings per share due to rising costs and tax rate changes [1][6][7][8]. Group 1: Government Operations Segment - BWXT's Government Operations segment is likely to see revenue growth due to higher manufacturing volumes of nuclear components for U.S. Government programs and increased design and engineering work in the defense market [1][2]. - The acquisition of Aerojet Ordnance Tennessee, Inc. is expected to provide positive synergies, further boosting revenues in this segment [2]. - The Zacks Consensus Estimate for this segment's first-quarter sales is $526.1 million, reflecting an 8% increase from the previous year [3][6]. Group 2: Commercial Operations Segment - The Commercial Operations segment is anticipated to benefit from higher sales of nuclear components and medical radioisotopes, driven by strong demand in the commercial nuclear power and medical markets [4]. - The Zacks Consensus Estimate for this segment's first-quarter sales is $134.6 million, indicating a 15% increase from the prior year [5][6]. Group 3: Overall Financial Expectations - BWXT's overall first-quarter sales are estimated at $657.2 million, representing an 8.8% increase year-over-year [6]. - The expected earnings per share for the first quarter is 73 cents, which indicates a year-over-year decline of 4% [8]. - Rising labor costs and a shift towards lower-margin programs are likely to negatively impact operating margins and overall bottom-line performance [7].
Oklo vs. BWX Technologies: Which Nuclear Innovator Stock to Buy?
ZACKS· 2025-04-22 13:46
Core Insights - The global clean energy industry is evolving, with nuclear energy stocks like OKLO Inc. and BWX Technologies gaining traction due to their low carbon emissions and increasing government support for small modular and microreactor technologies [1][2]. Summary of OKLO - Recent Achievements: OKLO has made significant strides in 2024, including signing a major corporate power agreement with Switch for 12 gigawatts (GW) of advanced nuclear power, claiming to have the largest order book in the advanced nuclear industry with a customer pipeline of 14 GW [3][4]. - Financial Stability: The company ended 2024 with cash and cash equivalents of $97.1 million, a substantial increase from $9.9 million at the end of 2023, and reported no notable debt, indicating solid financial stability [5]. - Challenges: OKLO has yet to generate revenue, with its first Aurora powerhouse expected to be deployed in 2027, leading to significant operating expenses and downward pressure on its bottom line [6][7]. Summary of BWXT - Recent Achievements: BWX Technologies ended 2024 with record bookings in Commercial Operations, driven by critical equipment for North America's first small modular reactor project, and a 21% growth in backlog [8][9]. - Financial Stability: The company concluded 2024 with cash and cash equivalents of $77 million, current debt of $13 million, and long-term debt of $1,043 million, suggesting a solid solvency position [10]. - Challenges: BWXT faces limited international exposure, being highly U.S.-centric, which restricts its revenue generation opportunities in international nuclear markets [11]. EPS Estimates Comparison - OKLO's 2025 earnings per share (EPS) is estimated at a loss of 43 cents, an improvement from a loss of 74 cents the previous year, but with a downward trend in estimates [12]. - BWXT's 2025 EPS is estimated at $3.50, reflecting a year-over-year improvement of 5.1%, with upward trending estimates [13]. Stock Price Performance - Over the past three months, BWXT has outperformed OKLO, with BWXT down 21.8% compared to OKLO's 47.4% decline, while OKLO has rallied 56.8% over the past year compared to BWXT's 7.2% growth [15]. Return on Equity (ROE) - BWXT exhibits a higher Return on Equity (ROE) compared to OKLO, indicating better efficiency in using shareholder equity to generate profits, while OKLO has a negative ROE due to incurring losses [16]. Investment Recommendation - BWXT is currently viewed as a more stable and financially sound investment opportunity, supported by solid revenue and operating cash flow, while OKLO, still in the pre-revenue phase, presents higher execution risk [20][21].
BWX (BWXT) Upgraded to Buy: Here's What You Should Know
ZACKS· 2025-04-10 17:01
Core Viewpoint - BWX Technologies (BWXT) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Institutional investors often base their valuation models on earnings estimates, leading to buying or selling actions that affect stock prices [4]. Company Performance and Outlook - The upgrade for BWX reflects an improvement in the company's underlying business, suggesting that investors may respond positively by driving the stock price higher [5]. - BWX is projected to earn $3.50 per share for the fiscal year ending December 2025, representing a year-over-year increase of 5.1% [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - BWX's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].
BWX (BWXT) Surges 11.7%: Is This an Indication of Further Gains?
ZACKS· 2025-04-10 14:45
Company Overview - BWX Technologies (BWXT) shares increased by 11.7% to close at $104.08, following a significant volume of trading, contrasting with a 3.9% loss over the past four weeks [1] - The recent surge in BWXT's share price is linked to a $2.6 billion award from the U.S. Department of Energy for managing and operating the Strategic Petroleum Reserve [1] Earnings Expectations - BWXT is projected to report quarterly earnings of $0.71 per share, reflecting a year-over-year decline of 6.6%, while revenues are expected to reach $653.05 million, an increase of 8.1% from the previous year [2] - The consensus EPS estimate for BWXT has been revised down by 3.2% over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] Industry Context - BWX is part of the Zacks Aerospace - Defense Equipment industry, where another company, Axon Enterprise (AXON), saw its shares rise by 11.1% to $559.84, despite a -4.3% return over the past month [4] - Axon's consensus EPS estimate remains unchanged at $1.34, representing a 16.5% increase from the previous year [5]
APTIM and BWX Technologies, Inc. Awarded $1.4 Billion Contract for Strategic Petroleum Reserve
Prnewswire· 2025-04-09 17:00
Core Insights - APTIM and BWX Technologies have been awarded a $1.4 billion contract by the US Department of Energy to manage and operate the Strategic Petroleum Reserve for a five-year term, with a potential five-year extension [1][2] - The Strategic Petroleum Reserve is the world's largest supply of emergency crude oil, holding 714 million barrels, aimed at minimizing disruptions in US petroleum supplies during international oil shortages [3] Company Overview - APTIM focuses on enhancing environmental quality, community resilience, and employee opportunities, providing integrated solutions in environmental, sustainability, and infrastructure sectors [4] - BWX Technologies is a Fortune 1000 company specializing in nuclear solutions for global security, clean energy, and environmental restoration, with approximately 7,800 employees and 14 major operating sites [5]
BWX Technologies: A Strong Nuclear Bet, But With Little Margin For Error
Seeking Alpha· 2025-04-04 12:19
Core Insights - BWX Technologies, Inc. (BWXT) is significantly influenced by federal projects, which account for approximately 80% of its revenue [1] - The company is enhancing its income through strategic acquisitions, including Aerojet Ordnance Tennessee and Kinectrics, which are expected to strengthen its market position [1]
BWX Technologies Poised For Growth In Nuclear Power, Medical Radioisotopes Says Analyst
Benzinga· 2025-04-01 18:36
Core Viewpoint - Seaport Global analyst Jeff Campbell initiated coverage on BWX Technologies Inc with a Buy rating and a price target of $145, highlighting the company's strong position in the U.S. Navy nuclear reactor market and its consistent gross margins [1][2]. Company Performance - BWX Technologies has demonstrated decades of strong performance, supported by a durable relationship with the U.S. Navy, which is expected to continue amid rising global conflicts [2]. - The company is recognized for its management's ability to enhance value through ancillary products and services related to its core business [2]. Government Contracts - BWX Technologies secured $2.1 billion in U.S. Naval contracts for building reactor components for submarines and aircraft carriers, indicating robust demand for its products [3]. Growth Potential - The company's commercial operations in Canada are expected to contribute to growth, with projections suggesting a decline in its EBITDA multiple over time due to EBITDA growth [3]. - The acquisition of Kinetrics is anticipated to enhance Canadian manufacturing capabilities, with Ontario planning to introduce its first commercial Small Modular Reactor (SMR) by 2028 [4]. Medical Division - BWXT Medical has significant growth potential, particularly with the regulatory approval of its Tc-99 platform and Ac-225, which could revolutionize cancer treatment through alpha radiation [5]. - The commercial division's growth in power applications and medical radioisotopes indicates that BWX Technologies is not solely reliant on its core business [5]. Manufacturing Capabilities - The company possesses comprehensive manufacturing capabilities related to nuclear radiation, constructing primary systems for naval nuclear propulsion that meet specific military requirements [6]. - BWX Technologies is the only private entity in the U.S. licensed to produce highly enriched uranium (HEU) for its reactors, maintaining a monopoly over U.S. Navy nuclear propulsion systems [8]. Innovation and Development - BWX Technologies is developing a mobile reactor system for the Department of Defense (Project Pele), which is in late-stage development, showcasing its expertise in small reactors [9]. - The company is also involved in building components for large-scale nuclear power generation facilities in Canada, supporting the CANDU heavy water reactor approach [10]. Market Demand - The demand for radionuclides in diagnostic and therapeutic applications is high, with the industry characterized as fragmented, high-margin, and ripe for consolidation [11]. - Projected first-quarter revenue for BWX Technologies is $602.1 million, with adjusted EPS estimated at $0.60, reflecting strong financial performance [11].
Nuclear Energy Stocks to Consider as Demand for Clean Power Grows
ZACKS· 2025-03-26 12:35
Nuclear energy is emerging as a key solution to the world's growing electricity demand and the transition to cleaner power sources. Unlike solar and wind, which depend on weather conditions, nuclear plants operate around the clock, ensuring an uninterrupted energy supply.With this increasing importance, nuclear energy-related stocks, such as BWX Technologies (BWXT) , GE Vernova Inc. (GEV) and Constellation Energy Corporation (CEG) , are becoming attractive investment options. Unlike other clean energy sourc ...